Paper3918869
Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S and 2 others. Eur J Immunol, 1985. Cited by 142 papers, by iCite.
Cite this record
ConductScience Library. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Papers, record 3918869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918869
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HLA Antigens | Major topic |
| Histocompatibility Antigens Class II | Major topic |
| Interferon-gamma | Major topic |
| Cell Line | |
| Cell Membrane | |
| Colonic Neoplasms | |
| DNA, Recombinant | |
| Dose-Response Relationship, Drug | |
| Glioma | |
| HLA-DQ Antigens | |
| HLA-DR Antigens | |
| Humans | |
| Interferon Type I | |
| Melanoma | |
| Molecular Weight | |
| beta 2-Microglobulin |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39956823 | Identification and characterization of cell niches in tissue from spatial omics data at single-cell resolution. | Nat Commun | 2025 | https://conductscience.org/library/papers/39956823 | PubMed |
| 30193111 | A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. | Cell | 2018 | https://conductscience.org/library/papers/30193111 | PubMed |
| 27141382 | Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27141382 | PubMed |
| 22358536 | Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells. | Cytotechnology | 1997 | https://conductscience.org/library/papers/22358536 | PubMed |
| 12679797 | A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. | Cancer Gene Ther | 2003 | https://conductscience.org/library/papers/12679797 | PubMed |
| 11839572 | Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells. | Am J Pathol | 2002 | https://conductscience.org/library/papers/11839572 | PubMed |
| 11083492 | The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer. | Gene Ther | 2000 | https://conductscience.org/library/papers/11083492 | PubMed |
| 8422663 | Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8422663 | PubMed |
| 8270604 | Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8270604 | PubMed |
| 8124687 | MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8124687 | PubMed |
| 8101473 | Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8101473 | PubMed |
| 7917907 | Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7917907 | PubMed |
| 7488605 | Effects of interferon alfa and gamma on human uveal melanoma cells in vitro. | Br J Ophthalmol | 1995 | https://conductscience.org/library/papers/7488605 | PubMed |
| 3862745 | Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes. | J Exp Med | 1985 | https://conductscience.org/library/papers/3862745 | PubMed |
| 3779716 | BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors? | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3779716 | PubMed |
| 3664532 | Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3664532 | PubMed |
| 3132343 | IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread. | Clin Exp Metastasis | 1988 | https://conductscience.org/library/papers/3132343 | PubMed |
| 3124997 | Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells. | Clin Exp Immunol | 1987 | https://conductscience.org/library/papers/3124997 | PubMed |
| 3117460 | HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. | Clin Exp Immunol | 1987 | https://conductscience.org/library/papers/3117460 | PubMed |
| 3114551 | [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia]. | Klin Wochenschr | 1987 | https://conductscience.org/library/papers/3114551 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-G | 3135 | PubTator's text mining | https://conductscience.org/library/genes/3135 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3918869
GET https://conductscience.org/api/papers/v1/3918869/cited_by?page=2